Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Chronic liver disease is surging in the US and no group is more affected than Asians and Pacific Islanders. Find out how Dr. Tomoaki Kato and Columbia Liver Asian Outreach is addressing this problem.
Almost all liver cancers develop after decades of chronic liver disease, but a new discovery by Columbia researchers, led by Robert Schwabe, MD, may lead to treatments that could break the link.